Michael Aagaard Andersen

Michael Aagaard Andersen

Assistant Professor


Publication year:
  1. 2023
  2. Published

    Polydimethylsiloxane as a more biocompatible alternative to glass in optogenetics

    Andersen, Michael Aagaard & Schouenborg, J., 2023, In: Scientific Reports. 13, 1, 12 p., 16090.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2021
  4. Published

    Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study

    Andersen, Michael Aagaard, Rostgaard, K., Niemann, Carsten & Hjalgrim, Henrik, 2021, In: Leukemia. 35, 3, p. 747-751 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2019
  6. Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and Implications

    Andersen, Michael Aagaard, Sotty, F., Jensen, P. H., Badolo, L., Jeggo, R., Smith, G. P. & Christensen, K. V., 7 Nov 2019, In: eNeuro. 6, 6

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 2018
  8. Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation

    Andersen, Michael Aagaard, Christensen, K. V., Badolo, L., Smith, G. P., Jeggo, R., Jensen, P. H., Andersen, K. J. & Sotty, F., Aug 2018, In: Neurobiology of Disease. 116, p. 13-27 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats

    Andersen, Michael Aagaard, Wegener, K. M., Larsen, S., Badolo, L., Smith, G. P., Jeggo, R., Jensen, P. H., Sotty, F., Christensen, K. V. & Thougaard, A., 15 Feb 2018, In: Toxicology. 395, p. 15-22 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 201649802